Method for preparing human meloma vaccine

Details Method for preparing human meloma vaccine Method for preparing human meloma vaccine

1989-01-19

1993-03-16

Lacey, David L.

Chemistry: molecular biology and microbiology

Spore forming or isolating process

530412, 424 88, 435243, C12N 506, A61K 3702, A61K 3900, A23J 304

Patent

active

051943840

ABSTRACT:
There is disclosed a method of preparing a vaccine suitable for administration to humans for the prevention or treatment of cancer. The vaccine is prepared by culturing human cancer cells in a serum-free medium and recovering from the culture medium the cell surface antigens shed from the human cancer cells during culturing. After purification, the collected or recovered shed antigens are employed to produce a vaccine consisting essentially of said antigens for the treatment or prevention of human cancer.

REFERENCES:
patent: 4415553 (1983-12-01), Zhabilor et al.
patent: 4434157 (1984-02-01), Olson
patent: 4879222 (1989-11-01), Alderman
Livingston et al. Cancer vol 56 No. 9 Nov. 1985.

Affiliated with

Also associated with

Rating

Method for preparing human meloma vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for preparing human meloma vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preparing human meloma vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-350420